Pluri Inc (PLUR)
5.86
-0.02
(-0.34%)
USD |
NASDAQ |
May 08, 16:00
5.86
0.00 (0.00%)
After-Hours: 20:00
Pluri Research and Development Expense (Quarterly): 2.964M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.964M |
| September 30, 2023 | 2.993M |
| June 30, 2023 | 3.522M |
| March 31, 2023 | 4.167M |
| December 31, 2022 | 3.785M |
| September 30, 2022 | 4.27M |
| June 30, 2022 | 5.361M |
| March 31, 2022 | 6.156M |
| December 31, 2021 | 6.507M |
| September 30, 2021 | 6.353M |
| June 30, 2021 | 8.485M |
| March 31, 2021 | 7.666M |
| December 31, 2020 | 7.977M |
| September 30, 2020 | 5.938M |
| June 30, 2020 | 5.838M |
| March 31, 2020 | 5.717M |
| December 31, 2019 | 4.64M |
| September 30, 2019 | 5.382M |
| June 30, 2019 | 5.58M |
| March 31, 2019 | 7.827M |
| December 31, 2018 | 6.256M |
| September 30, 2018 | 6.764M |
| June 30, 2018 | 5.932M |
| March 31, 2018 | 6.382M |
| December 31, 2017 | 5.638M |
| Date | Value |
|---|---|
| September 30, 2017 | 4.677M |
| June 30, 2017 | 4.555M |
| March 31, 2017 | 6.337M |
| December 31, 2016 | 5.202M |
| September 30, 2016 | 4.998M |
| June 30, 2016 | 4.359M |
| March 31, 2016 | 5.756M |
| December 31, 2015 | 5.337M |
| September 30, 2015 | 4.128M |
| June 30, 2015 | 4.163M |
| March 31, 2015 | 6.094M |
| December 31, 2014 | 4.879M |
| September 30, 2014 | 4.037M |
| June 30, 2014 | 4.464M |
| March 31, 2014 | 6.848M |
| December 31, 2013 | 5.107M |
| September 30, 2013 | 3.123M |
| June 30, 2013 | 5.92M |
| March 31, 2013 | 4.962M |
| December 31, 2012 | 3.653M |
| September 30, 2012 | 2.698M |
| June 30, 2012 | 2.337M |
| March 31, 2012 | 2.91M |
| December 31, 2011 | 1.067M |
| September 30, 2011 | 2.844M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
2.964M
Minimum
Dec 2023
8.485M
Maximum
Jun 2021
5.437M
Average
5.58M
Median
Jun 2019
Research and Development Expense (Quarterly) Benchmarks
| InspireMD Inc | 2.035M |
| Taro Pharmaceutical Industries Ltd | 13.59M |
| BiomX Inc | 2.675M |
| Alpha Tau Medical Ltd | 7.49M |
| Holdco Nuvo Group DG Ltd | -- |